
In the exports segment, as per Care Ratings, the regulated markets (US, European Union) are expected to maintain strong growth…
Market watchlist this week, October 12: Track key stocks like HDFC Bank, Tata Steel, and Bajaj Finance as earnings season…
In early September, the government slashed GST rates on all pharmaceutical formulations from 12% to 5%. Exemptions were also provided…
With 1,115 self-made entrepreneurs and 358 billionaires, India’s new rich are rewriting the rules of wealth creation. From AI founders…
Enhancing intellectual property enforcement and offering tax benefits on R&D expenditure can further motivate innovators. Skill development programmes for scientists,…
The deal, executed through Indegene’s subsidiary ILSL Inc., aims to strengthen Indegene’s commercialisation portfolio and expand its AI-powered marketing and…
Nomura warns Sun Pharma faces $100 million risk from potential US tariffs on specialty drugs. Explore the impact on Indian…
Large Indian generic exporters are expanding their presence in European markets via a spate of acquisitions in that region, at…
Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.
Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…
Indian benchmark indices, Sensex and Nifty, extended their losing streak to a sixth session on Friday, dropping nearly 1% and…
Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…
Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.
Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!
Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.
His latest order identifies more than 45 categories for zero import tariffs from “aligned partners” who clinch framework pacts to…
With increasing government policy support, innovation, and digitalisation, many Indian businesses are growing at a fast pace. Here are three…
India’s $3 bn contract research, development and manufacturing (CRDMO) sector is set to grow at 18% CAGR till FY30, says…